SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-09-008924
Filing Date
2009-01-21
Accepted
2009-01-21 14:24:15
Documents
6
Period of Report
2008-12-23
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K AMENDMENT NO. 2 d8ka.htm 8-K/A 18129
2 LETTER FROM BDO SEIDMAN, LLP TO THE SECURITIES AND EXCHANGE COMMISSION dex161.htm EX-16.1 1939
4 GRAPHIC g12694corresp.jpg GRAPHIC 30276
5 GRAPHIC g12694im1.jpg GRAPHIC 33245
6 GRAPHIC g12694im2.jpg GRAPHIC 4681
7 filename7.htm CORRESP 8184
  Complete submission text file 0001193125-09-008924.txt   124309
Mailing Address 601 BIOTECH DRIVE RICHMOND VA 23235
Business Address 601 BIOTECH DRIVE RICHMOND VA 23235 8046483820
COMMONWEALTH BIOTECHNOLOGIES INC (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-13467 | Film No.: 09536475
SIC: 8731 Services-Commercial Physical & Biological Research